Hutch News

International symposium focuses on lobular breast cancer

International symposium focuses on lobular breast cancer

Clinicians, researchers and patients from around the world gather in Pittsburgh to honor Seattle advocate, discuss understudied disease
Hutch NewsOctober 06, 2023
What’s new in breast cancer research? SABCS20 goes virtual

What’s new in breast cancer research? SABCS20 goes virtual

Hutch scientists share findings on treatment, imaging, CAR T therapy, COVID-19’s impact on cancer patients and more
Hutch NewsDecember 18, 2020
Understanding Rita Wilson's diagnosis

Understanding Rita Wilson's diagnosis

Oncologist Dr. V.K. Gadi explains the actress's type of breast cancer: lobular carcinoma in situ
Hutch NewsApril 15, 2015
Combined hormone therapy increases risk of lobular breast cancer fourfold after just three years of use

Combined hormone therapy increases risk of lobular breast cancer fourfold after just three years of use

Fred Hutchinson Cancer Research Center leads first study designed to evaluate the association between combined HRT use and the risk of lobular breast cancers
News ReleasesJanuary 15, 2008
Combined hormone therapy increases risk of lobular breast cancer fourfold after just three years of use

Combined hormone therapy increases risk of lobular breast cancer fourfold after just three years of use

Center leads first study designed to evaluate the association between combined HRT use and the risk of lobular breast cancers
Hutch NewsJanuary 07, 2008